logo

ICCC

Immucell·NASDAQ
--
--(--)
--
--(--)

ICCC fundamentals

Immucell (ICCC) expects to report earnings on May 12, 2022, with estimated revenue of -- (YoY --), and EPS at -- (YoY --).
Revenue estimate / YoY
--
--
EPS estimate / YoY
--
--
Report date
May 12, 2022

Earnings

EPS
Revenue

Revenue & Expenses

ICCC has released its 2025 Q4 earnings report, with revenue of 7.63M, reflecting a YoY change of -1.61%, and net profit of -2.85M, showing a YoY change of -653.71%. The Sankey diagram below clearly presents ICCC's revenue sources and cost distribution.

Key Indicators

Immucell (ICCC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Immucell (ICCC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Immucell (ICCC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Immucell (ICCC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Immucell (ICCC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Immucell (ICCC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield